These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 8831577

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y, Gannon J, Masutani M, Nakagama H, Sasagawa T, Inoue M, Masamune Y, Yamashita K.
    Exp Cell Res; 2001 Jan 01; 262(1):37-48. PubMed ID: 11120603
    [Abstract] [Full Text] [Related]

  • 5. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA.
    Oncogene; 2000 Aug 10; 19(34):3858-65. PubMed ID: 10951579
    [Abstract] [Full Text] [Related]

  • 6. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ.
    Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295
    [Abstract] [Full Text] [Related]

  • 7. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Apr 15; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 8. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M.
    Cancer Res; 1997 Mar 01; 57(5):870-4. PubMed ID: 9041188
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R.
    Oncogene; 2006 Feb 16; 25(7):1053-69. PubMed ID: 16205633
    [Abstract] [Full Text] [Related]

  • 15. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
    Medema RH, Klompmaker R, Smits VA, Rijksen G.
    Oncogene; 1998 Jan 29; 16(4):431-41. PubMed ID: 9484832
    [Abstract] [Full Text] [Related]

  • 16. Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells.
    Lu Y, Tatsuka M, Takebe H, Yagi T.
    Mol Carcinog; 2000 Sep 29; 29(1):1-7. PubMed ID: 11020241
    [Abstract] [Full Text] [Related]

  • 17. Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1.
    de Toledo SM, Azzam EI, Keng P, Laffrenier S, Little JB.
    Cell Growth Differ; 1998 Nov 29; 9(11):887-96. PubMed ID: 9831241
    [Abstract] [Full Text] [Related]

  • 18. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression.
    Del Sal G, Murphy M, Ruaro E, Lazarevic D, Levine AJ, Schneider C.
    Oncogene; 1996 Jan 04; 12(1):177-85. PubMed ID: 8552389
    [Abstract] [Full Text] [Related]

  • 19. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.
    Chen X, Bargonetti J, Prives C.
    Cancer Res; 1995 Oct 01; 55(19):4257-63. PubMed ID: 7671232
    [Abstract] [Full Text] [Related]

  • 20. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW, Johnson RT, Presnell SC, Mohler JL, French FS.
    J Androl; 2001 Oct 01; 22(4):537-48. PubMed ID: 11451350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.